Trials / Completed
CompletedNCT06262347
Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD
NIDA CTN Protocol 0150: Personally-Tailored Opioid-overdose and Medication for Opioid Use Disorder (MOUD) Education (TOME) for Pregnant and Postpartum Persons in MOUD: A Pilot Randomized Trial (TOME Trial)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 131 (actual)
- Sponsor
- T. John Winhusen, PhD · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the ability of TOME to increase Medication for Opioid Use Disorder (MOUD) and opioid-overdose knowledge in pregnant and postpartum persons.
Detailed description
This is an intent-to-treat, two-arm, open-label, randomized controlled trial. Eligible participants will be randomized in a 1:1 ratio to TOME or Control, balancing on site. Participants will receive the assigned intervention following randomization and will complete a three week follow-up assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Personally-Tailored Opioid-overdose and Medication for opioid use disorder (MOUD) Education (TOME) | The TOME intervention is a modified version of the personally-tailored opioid overdose prevention education and naloxone distribution (PTOEND) intervention (Winhusen et al. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids. Drug Alcohol Depend. Nov 1 2020;216:108265). Modifications include updating the knowledge assessment/education to reflect changes in the drug supply (i.e., the current high prevalence of fentanyl and increasing prevalence of xylazine) and the addition of items specific to pregnancy. Like PTOEND, TOME is a computer-guided intervention which utilizes REDCap to complete assessments and automatically generate personally-tailored feedback reports. |
| BEHAVIORAL | Control | Participants randomized to the control condition will be offered three SAMHSA handouts. |
Timeline
- Start date
- 2024-06-13
- Primary completion
- 2024-11-11
- Completion
- 2024-11-11
- First posted
- 2024-02-16
- Last updated
- 2025-05-11
- Results posted
- 2025-05-11
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06262347. Inclusion in this directory is not an endorsement.